-
Ablashi D, Chatlynne L, Cooper H. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa[J]. Br J Cancer, 1999, 81(): 893-897. doi: 10.1038/sj.bjc.6690782
-
Ablashi D V, Chatlynne L G, Whitman J E Jr. Spectrum of Kaposi's sarcoma-associated herpes-virus, or human herpesvirus 8, diseases[J]. Clin Microbiol Rev, 2002, 15(): 439-464. doi: 10.1128/CMR.15.3.439-464.2002
-
Albini A, Paglieri I, Orengo G. The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line[J]. AIDS, 1997, 11(): 713-721. doi: 10.1097/00002030-199706000-00003
-
Aoki Y, Tosato G. Targeted inhibition of angio-genic factors in AIDS-related disorders[J]. Curr Drug Targets Infect Disord, 2003, 3(): 115-128. doi: 10.2174/1568005033481222
-
Aoki Y, Tosato G. HIV-1 Tat enhances Kaposi sar-coma-associated herpesvirus (KSHV) infectivity[J]. Blood, 2004, 104(): 810-814. doi: 10.1182/blood-2003-07-2533
-
Atkinson J, Edlin B R, Engels E A. Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco[J]. J Infect Dis, 2003, 187(): 974-981. doi: 10.1086/jid.2003.187.issue-6
-
Bechtel J T, Liang Y, Hvidding J. Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells[J]. J Virol, 2003, 77(): 6474-6481. doi: 10.1128/JVI.77.11.6474-6481.2003
-
Beral V. Epidemiology of Kaposi's sarcoma[J]. Cancer Surv, 1991, 10(): 5-22.
-
Beral V, Peterman T A, Berkelman R L. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?[J]. Lancet, 1990, 335(): 123-128. doi: 10.1016/0140-6736(90)90001-L
-
Blackbourn D J, Lennette E T, Ambroziak J. Human herpesvirus 8 detection in nasal secretions and saliva[J]. J Infect Dis, 1998, 177(): 213-216. doi: 10.1086/jid.1998.177.issue-1
-
Blackbourn D J, Osmond D, Levy J A. Increased human herpesvirus 8 seroprevalence in young homosexual men who have multiple sex contacts with different partners[J]. J Infect Dis, 1999, 179(): 237-239. doi: 10.1086/jid.1999.179.issue-1
-
Borkovic S P, Schwartz R A. Kaposi's sarcoma presenting in the homosexual man --a new and striking phenomenon![J]. Ariz Med, 1981, 38(): 902-904.
-
Burysek L, Yeow W S, Lubyova B. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300[J]. J Virol, 1999, 73(): 7334-7342.
-
Cannon M J, Dollard S C, Black J B. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus[J]. AIDS, 2003, 17(): 215-222. doi: 10.1097/00002030-200301240-00012
-
Carbone A, Gaidano G. HHV-8-positive body-cavity-based lymphoma: a novel lymphoma entity[J]. Br J Haematol, 1997, 97(): 515-522. doi: 10.1046/j.1365-2141.1997.00064.x
-
Caselli E, Menegazzi P, Bracci A. Human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) ORF50 interacts synergistically with the tat gene product in transactivating the human immunodeficiency virus type 1 LTR[J]. J Gen Virol, 2001, 82(): 1965-1970. doi: 10.1099/0022-1317-82-8-1965
-
Caselli E, Galvan M, Santoni F. Human herpesvirus-8 (Kaposi's sarcoma-associated virus) ORF50 increases in vitro cell susceptibility to human immunodeficiency virus type 1 infection[J]. J Gen Virol, 2003, 84(): 1123-1131. doi: 10.1099/vir.0.18799-0
-
Caselli E, Galvan M, Cassai E. Transient expression of human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) ORF50 enhances HIV-1 replication[J]. Intervirology, 2003, 46(): 141-149. doi: 10.1159/000071454
-
Caselli E, Galvan M, Cassai E. Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reacti-vation in latently infected cells[J]. Blood, 2005, 106(): 2790-2797. doi: 10.1182/blood-2005-04-1390
-
Cathomas G, McGandy C E, Terracciano L M. Detection of herpesvirus-like DNA by nested PCR on archival skin biopsy specimens of various forms of Kaposi sarcoma[J]. J Clin Pathol, 1996, 49(): 631-633. doi: 10.1136/jcp.49.8.631
-
Cesarman E, Chang Y, Moore P S. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas[J]. N Engl J Med, 1995, 332(): 1186-1191. doi: 10.1056/NEJM199505043321802
-
Cesarman E. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproli-ferative diseases[J]. Recent Results Cancer Res, 2002, 159(): 27-37. doi: 10.1007/978-3-642-56352-2
-
Chang Y, Cesarman E, Pessin M S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma[J]. Science, 1994, 266(): 1865-1869. doi: 10.1126/science.7997879
-
Chatlynne L G, Ablashi D V. Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV)[J]. Semin Cancer Biol, 1999, 9(): 175-185. doi: 10.1006/scbi.1998.0089
-
Chatlynne L G, Lapps W, Handy M. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immuno-deficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosor-bent assay[J]. Blood, 1998, 92(): 53-58.
-
Cheng E H, Nicholas J, Bellows D S. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak[J]. Proc Natl Acad Sci U S A, 1997, 94(): 690-694. doi: 10.1073/pnas.94.2.690
-
Child E S, Mann D J. Novel properties of the cyclin encoded by Human Herpesvirus 8 that facilitate exit from quiescence[J]. Oncogene, 2001, 20(): 3311-3322. doi: 10.1038/sj.onc.1204447
-
Couty J P, Geras-Raaka E, Weksler B B. Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor signals through multiple pathways in endothelial cells[J]. J Biol Chem, 2001, 276(): 33805-33811. doi: 10.1074/jbc.M104631200
-
de-The G, Bestetti G, van Beveren M. Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease syndrome-related epidemic of Kaposi's sarcoma in East Africa[J]. J Natl Cancer Inst, 1999, 91(): 1888-1889. doi: 10.1093/jnci/91.21.1888
-
Dedicoat M, Newton R, Alkharsah K R. Mother-to-child transmission of human herpesvirus-8 in South Africa[J]. J Infect Dis, 2004, 190(): 1068-1075. doi: 10.1086/jid.2004.190.issue-6
-
Duus K M, Lentchitsky V, Wagenaar T. Wild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells[J]. J Virol, 2004, 78(): 4074-4084. doi: 10.1128/JVI.78.8.4074-4084.2004
-
Enbom M, Sheldon J, Lennette E. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study[J]. J Med Virol, 2000, 62(): 498-504. doi: 10.1002/(ISSN)1096-9071
-
Engels E A, Sinclair M D, Biggar R J. Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-saharan Africa and Malta[J]. Int J Cancer, 2000, 88(): 1003-1008. doi: 10.1002/(ISSN)1097-0215
-
Ensoli B, Sgadari C, Barillari G. Biology of Kaposi's sarcoma[J]. Eur J Cancer, 2001, 37(): 1251-1269. doi: 10.1016/S0959-8049(01)00121-6
-
Ensoli B, Sturzl M, Monini P. Reactivation and role of HHV-8 in Kaposi's sarcoma initiation[J]. Adv Cancer Res, 2001, 81(): 161-200. doi: 10.1016/S0065-230X(01)81005-8
-
Field N, Low W, Daniels M. KSHV vFLIP binds to IKK-gamma to activate IKK[J]. J Cell Sci, 2003, 116(): 3721-3728. doi: 10.1242/jcs.00691
-
Friborg J Jr, Kong W, Hottiger M O. p53 inhibition by the LANA protein of KSHV protects against cell death[J]. Nature, 1999, 402(): 889-894.
-
Friedman-Kien A E. Disseminated Kaposi's sarcoma syndrome in young homosexual men[J]. J Am Acad Dermatol, 1981, 5(): 468-471. doi: 10.1016/S0190-9622(81)80010-2
-
Gambus G, Bourboulia D, Esteve A. Prevalence and distribution of HHV-8 in different subpopu-lations, with and without HIV infection, in Spain[J]. AIDS, 2001, 15(): 1167-1174. doi: 10.1097/00002030-200106150-00012
-
Gao S J, Boshoff C, Jayachandra S. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway[J]. Oncogene, 1997, 15(): 1979-1985. doi: 10.1038/sj.onc.1201571
-
Gao S J, Kingsley L, Li M. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma[J]. Nat Med, 1996, 2(): 925-928. doi: 10.1038/nm0896-925
-
Gessain A, Mauclere P, van Beveren M. Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa[J]. Int J Cancer, 1999, 81(): 189-192. doi: 10.1002/(ISSN)1097-0215
-
Giraldo G, Beth E, Haguenau F. Herpes-type virus particles in tissue culture of Kaposi's sarcoma from different geographic regions[J]. J Natl Cancer Inst, 1972, 49(): 1509-1526. doi: 10.1093/jnci/49.6.1509
-
Goedert J J, Cote T R, Virgo P. Spectrum of AIDS-associated malignant disorders[J]. Lancet, 1998, 351(): 1833-1839. doi: 10.1016/S0140-6736(97)09028-4
-
Gottlieb G J, Ragaz A, Vogel J V. A preliminary communication on extensively disseminated Kaposi's sarcoma in young homosexual men[J]. Am J Dermatopathol, 1981, 3(): 111-114. doi: 10.1097/00000372-198100320-00002
-
Grossman Z, Iscovich J, Schwartz F. Absence of Kaposi sarcoma among Ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus 8[J]. Mayo Clin Proc, 2002, 77(): 905-909. doi: 10.1016/S0025-6196(11)62256-8
-
Guasparri I, Keller S A, Cesarman E. KSHV vFLIP is essential for the survival of infected lymphoma cells[J]. J Exp Med, 2004, 199(): 993-1003. doi: 10.1084/jem.20031467
-
Guo H G, Pati S, Sadowska M. Tumorigenesis by human herpesvirus 8 vGPCR is accele-rated by human immunodeficiency virus type 1 Tat[J]. J Virol, 2004, 78(): 9336-9342. doi: 10.1128/JVI.78.17.9336-9342.2004
-
Gwack Y, Hwang S, Byun H. Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis[J]. J Virol, 2001, 75(): 6245-6248. doi: 10.1128/JVI.75.13.6245-6248.2001
-
Hengge U R, Ruzicka T, Tyring S K. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma[J]. Lancet Infect Dis, 2002, 2(): 344-352. doi: 10.1016/S1473-3099(02)00288-8
-
Hideshima T, Chauhan D, Teoh G. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6[J]. Clin Cancer Res, 2000, 6(): 1180-1189.
-
Huang L M, Chao M F, Chen M Y. Reciprocal regulatory interaction between human herpes-virus 8 and human immunodeficiency virus type 1[J]. J Biol Chem, 2001, 276(): 13427-13432. doi: 10.1074/jbc.M011314200
-
Hymes K B, Cheung T, Greene J B. Kaposi's sarcoma in homosexual men-a report of eight cases[J]. Lancet, 1981, 2(): 598-600.
-
Hyun T S, Subramanian C, Cotter M A 2nd. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodefi-ciency virus type 1 in human cells[J]. J Virol, 2001, 75(): 8761-8771. doi: 10.1128/JVI.75.18.8761-8771.2001
-
Iscovich J, Boffetta P, Franceschi S. Classic kaposi sarcoma: epidemiology and risk factors[J]. Cancer, 2000, 88(): 500-517. doi: 10.1002/(ISSN)1097-0142
-
Jacobson L P, Jenkins F J, Springer G. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma[J]. J Infect Dis, 2000, 181(): 1940-1949. doi: 10.1086/jid.2000.181.issue-6
-
Juhasz A, Remenyik E, Konya J. Prevalence and age distribution of human herpesvirus-8 specific antibodies in Hungarian blood donors[J]. J Med Virol, 2001, 64(): 526-530. doi: 10.1002/jmv.1081
-
Juhasz I, Albelda S M, Elder D E. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice[J]. Am J Pathol, 1993, 143(): 528-537.
-
Kaaya S F, Leshabari M T, Mbwambo J K. Risk behaviors and vulnerability to HIV infection among Tanzanian youth[J]. J Health Popul Dev Ctries, 1998, 1(): 51-60.
-
Kaposi M. Idiopathisches multiples Pigmentsarkom der Haut[J]. Arch Dermatol Syph, 1872, 4(): 265-273. doi: 10.1007/BF01830024
-
Kirchhoff S, Sebens T, Baumann S. Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter[J]. J Immunol, 2002, 168(): 1226-1234. doi: 10.4049/jimmunol.168.3.1226
-
Lang M E, Lottersberger C, Roth B. Induction of apoptosis in Kaposi's sarcoma spindle cell cultures by the subunits of human chorionic gonadotropin[J]. AIDS, 1997, 11(): 1333-1340.
-
Lennette E T, Blackbourn D J, Levy J A. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients[J]. Lancet, 1996, 348(): 858-861. doi: 10.1016/S0140-6736(96)03240-0
-
Li M, Lee H, Yoon D W. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin[J]. J Virol, 1997, 71(): 1984-1991.
-
Liu L, Eby M T, Rathore N. The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex[J]. J Biol Chem, 2002, 277(): 13745-13751. doi: 10.1074/jbc.M110480200
-
Lubyova B, Pitha P M. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors[J]. J Virol, 2000, 74(): 8194-8201. doi: 10.1128/JVI.74.17.8194-8201.2000
-
Martin J N, Ganem D E, Osmond D H. Sexual transmission and the natural history of human herpesvirus 8 infection[J]. N Engl J Med, 1998, 338(): 948-954. doi: 10.1056/NEJM199804023381403
-
Martin R W 3rd, Hood A F, Farmer E R. Kaposi sarcoma[J]. Medicine (Baltimore), 1993, 72(): 245-261. doi: 10.1097/00005792-199307000-00004
-
Matta H, Chaudhary P M. Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP)[J]. Proc Natl Acad Sci U S A, 2004, 101(): 9399-9404. doi: 10.1073/pnas.0308016101
-
Mayama S, Cuevas L E, Sheldon J. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents[J]. Int J Cancer, 1998, 77(): 817-820. doi: 10.1002/(ISSN)1097-0215
-
Mbulaiteye S M, Biggar R J, Goedert J J. Immune deficiency and risk for malignancy among persons with AIDS[J]. J Acquir Immune Defic Syndr, 2003, 32(): 527-533. doi: 10.1097/00126334-200304150-00010
-
Mbulaiteye S M, Pfeiffer R M, Whitby D. Human herpesvirus 8 infection within families in rural Tanzania[J]. J Infect Dis, 2003, 187(): 1780-1785. doi: 10.1086/jid.2003.187.issue-11
-
Mendez J C, Procop G W, Espy M J. Relationship of HHV8 replication and Kaposi's sarcoma after solid organ transplantation[J]. Transplantation, 1999, 67(): 1200-1201. doi: 10.1097/00007890-199904270-00022
-
Merat R, Amara A, Lebbe C. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reacti-vation[J]. Int J Cancer, 2002, 97(): 791-795. doi: 10.1002/(ISSN)1097-0215
-
Mercader M, Taddeo B, Panella J R. Induction of HHV-8 lytic cycle replication by inflam-matory cytokines produced by HIV-1-infected T cells[J]. Am J Pathol, 2000, 156(): 1961-1971. doi: 10.1016/S0002-9440(10)65069-9
-
Mercader M, Nickoloff B J, Foreman K E. Induction of human immunodeficiency virus 1 replication by human herpesvirus 8[J]. Arch Pathol Lab Med, 2001, 125(): 785-789.
-
Molden J, Chang Y, You Y. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit[J]. J Biol Chem, 1997, 272(): 19625-19631. doi: 10.1074/jbc.272.31.19625
-
Montaner S, Sodhi A, Pece S. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B[J]. Cancer Res, 2001, 61(): 2641-2648.
-
Moore P S, Chang Y. Molecular virology of Kaposi's sarcoma-associated herpesvirus[J]. Philos Trans R Soc Lond B Biol Sci, 2001, 356(): 499-516. doi: 10.1098/rstb.2000.0777
-
Moore P S, Kingsley L A, Holmberg S D. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma[J]. AIDS, 1996, 10(): 175-180. doi: 10.1097/00002030-199602000-00007
-
Moore P S, Gao S J, Dominguez G. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae[J]. J Virol, 1996, 70(): 549-558.
-
Munshi N, Ganju R K, Avraham S. Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor activation of c-jun amino-terminal kinase/stress-activated protein kinase and lyn kinase is mediated by related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2[J]. J Biol Chem, 1999, 274(): 31863-31867. doi: 10.1074/jbc.274.45.31863
-
Nador R G, Cesarman E, Chadburn A. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus[J]. Blood, 1996, 88(): 645-656.
-
Nakamura H, Li M, Zarycki J. Inhibition of p53 tumor suppressor by viral interferon regulatory factor[J]. J Virol, 2001, 75(): 7572-7582. doi: 10.1128/JVI.75.16.7572-7582.2001
-
Neipel F, Albrecht J C, Fleckenstein B. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity?[J]. J Virol, 1997, 71(): 4187-4192.
-
O'Brien T R, Kedes D, Ganem D. Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma[J]. J Infect Dis, 1999, 180(): 1010-1017. doi: 10.1086/jid.1999.180.issue-4
-
Oettle A G. Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environ-mental or genetic causes[J]. Acta Unio Int Contra Cancrum, 1962, 18(): 330-363.
-
Olsen S J, Chang Y, Moore P S. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985[J]. AIDS, 1998, 12(): 1921-1925. doi: 10.1097/00002030-199814000-00024
-
Osborne J, Moore P S, Chang Y. KSHV-encoded viral IL-6 activates multiple human IL-6 signaling path-ways[J]. Hum Immunol, 1999, 60(): 921-927. doi: 10.1016/S0198-8859(99)00083-X
-
Pati S, Cavrois M, Guo H G. Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis[J]. J Virol, 2001, 75(): 8660-8673. doi: 10.1128/JVI.75.18.8660-8673.2001
-
Pauk J, Huang M L, Brodie S J. Mucosal shedding of human herpesvirus 8 in men[J]. N Engl J Med, 2000, 343(): 1369-1377. doi: 10.1056/NEJM200011093431904
-
Plancoulaine S, Abel L, van Beveren M. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population[J]. Lancet, 2000, 356(): 1062-1065. doi: 10.1016/S0140-6736(00)02729-X
-
Plancoulaine S, Abel L, Tregouet D. Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area[J]. Cancer Res, 2004, 64(): 8782-8787. doi: 10.1158/0008-5472.CAN-04-2000
-
Preiser W, Szep N I, Lang D. Kaposi's sarcoma-associated herpesvirus seroprevalence in selected german patients: evaluation by different test systems[J]. Med Microbiol Immunol, 2001, 190(): 121-127.
-
Rabkin C S, Janz S, Lash A. Monoclonal origin of multicentric Kaposi's sarcoma lesions[J]. N Engl J Med, 1997, 336(): 988-993. doi: 10.1056/NEJM199704033361403
-
Radkov S A, Kellam P, Boshoff C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells[J]. Nat Med, 2000, 6(): 1121-1127. doi: 10.1038/80459
-
Regamey N, Cathomas G, Schwager M. High human herpesvirus 8 seroprevalence in the homose-xual population in Switzerland[J]. J Clin Microbiol, 1998, 36(): 1784-1786.
-
Renne R, Blackbourn D, Whitby D. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells[J]. J Virol, 1998, 72(): 5182-5188.
-
Renne R, Lagunoff M, Zhong W. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions[J]. J Virol, 1996, 70(): 8151-8154.
-
Rivas C, Thlick A E, Parravicini C. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53[J]. J Virol, 2001, 75(): 429-438. doi: 10.1128/JVI.75.1.429-438.2001
-
Russo J J, Bohenzky R A, Chien M C. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)[J]. Proc Natl Acad Sci U S A, 1996, 93(): 14862-14867. doi: 10.1073/pnas.93.25.14862
-
Samaniego F, Young D, Grimes C. Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts[J]. Cell Growth Differ, 2002, 13(): 387-395.
-
Sarek G, Jarviluoma A, Ojala P M. KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lym-phomas[J]. Blood, 2006, 107(): 725-732. doi: 10.1182/blood-2005-06-2534
-
Sarid R, Flore O, Bohenzky R A. Transcri-ption mapping of the Kaposi's sarcoma-associated herpes-virus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1)[J]. J Virol, 1998, 72(): 1005-1012.
-
Sarid R, Sato T, Bohenzky R A. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue[J]. Nat Med, 1997, 3(): 293-298. doi: 10.1038/nm0397-293
-
Schulz T F. KSHV (HHV8) infection[J]. J Infect, 2000, 41(): 125-129. doi: 10.1053/jinf.2000.0712
-
Schwarz M, Murphy P M. Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor cons-titutively activates NF-kappa B and induces proinflam-matory cytokine and chemokine production via a C-terminal signaling determinant[J]. J Immunol, 2001, 167(): 505-513. doi: 10.4049/jimmunol.167.1.505
-
Seo T, Lee D, Shim Y S. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpes-virus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death[J]. J Virol, 2002, 76(): 8797-8807. doi: 10.1128/JVI.76.17.8797-8807.2002
-
Seo T, Park J, Lee D. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis[J]. J Virol, 2001, 75(): 6193-6198. doi: 10.1128/JVI.75.13.6193-6198.2001
-
Shin Y C, Nakamura H, Liang X. Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1[J]. J Virol, 2006, 80(): 2257-2266. doi: 10.1128/JVI.80.5.2257-2266.2006
-
Siegal F P, Lopez C, Hammer G S. Severe acquired immunodeficiency in male homosexuals, mani-fested by chronic perianal ulcerative herpes simplex lesions[J]. N Engl J Med, 1981, 305(): 1439-1444. doi: 10.1056/NEJM198112103052403
-
Sitas F, Carrara H, Beral V. Antibodies against human herpesvirus 8 in black South African patients with cancer[J]. N Engl J Med, 1999, 340(): 1863-1871. doi: 10.1056/NEJM199906173402403
-
Smit M J, Verzijl D, Casarosa P. Kaposi's sarcoma-associated herpesvirus-encoded G protein-cou-pled receptor ORF74 constitutively activates p44/p42 MAPK and Akt via G(i) and phospholipase C-dependent signaling pathways[J]. J Virol, 2002, 76(): 1744-1752. doi: 10.1128/JVI.76.4.1744-1752.2002
-
Soulier J, Grollet L, Oksenhendler E. Kaposi's sarcoma-associated herpesvirus-like DNA se-quences in multicentric Castleman's disease[J]. Blood, 1995, 86(): 1276-1280.
-
Sternbach G, Varon J. Moritz Kaposi: idiopathic pigmented sarcoma of the skin[J]. J Emerg Med, 1995, 13(): 671-674. doi: 10.1016/0736-4679(95)00077-N
-
Sturzl M, Hohenadl C, Zietz C. Expression of K13/v-FLIP gene of human herpesvirus 8 and apo-ptosis in Kaposi's sarcoma spindle cells[J]. J Natl Cancer Inst, 1999, 91(): 1725-1733. doi: 10.1093/jnci/91.20.1725
-
Sun Q, Matta H, Chaudhary P M. Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB path-way and functionally cooperates with Tat[J]. Retrovirology, 2005, 2(): 9-. doi: 10.1186/1742-4690-2-9
-
Wan X, Wang H, Nicholas J. Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6[J]. J Virol, 1999, 73(): 8268-8278.
-
West J T, Wood C. The role of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expres-sion[J]. Oncogene, 2003, 22(): 5150-5163. doi: 10.1038/sj.onc.1206555
-
Whitby D, Howard M R, Tenant-Flowers M. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma[J]. Lancet, 1995, 346(): 799-802. doi: 10.1016/S0140-6736(95)91619-9
-
Whitby D, Luppi M, Barozzi P. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy[J]. J Natl Cancer Inst, 1998, 90(): 395-397. doi: 10.1093/jnci/90.5.395
-
Zeng Y, Zhang X, Huang Z. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling[J]. J Virol, 2007, 81(): 2401-2417. doi: 10.1128/JVI.02024-06
-
Zhu F X, Chong J M, Wu L. Virion proteins of Kaposi's sarcoma-associated herpesvirus[J]. J Virol, 2005, 79(): 800-811. doi: 10.1128/JVI.79.2.800-811.2005
-
Ziegler J L, Newton R, Katongole-Mbidde E. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda[J]. AIDS, 1997, 11(): 1619-1626. doi: 10.1097/00002030-199713000-00011